BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Delcath Systems to Host Third Quarter 2026 Earnings Call

  October 26, 2026

   · 

  2 min read
• Press Releases

  U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephrology Kidney Week

  October 26, 2026

   · 

  13 min read
• Press Releases

  Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)

  October 26, 2026

   · 

  12 min read
• Press Releases

  X9 Receives FDA Breakthrough Device Designation for Investigational Dialysis Cannulation System and Completes Second Clinical Study

  October 26, 2026

   · 

  3 min read
• Press Releases

  Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call

  October 26, 2026

   · 

  1 min read
• Press Releases

  More Than 1 in 10 People Receive Medically Actionable Genetic Results Through 23andMe, Analysis of Nearly 6 Million Participants Finds

  October 26, 2026

   · 

  3 min read
• Press Releases

  Avacta Group plc: Faridoxorubicin Treatment Results in Near Doubling of Progression-Free Survival and Clinically Meaningful Tumor Shrinkage in Most Patients with Salivary Gland Cancers

  October 26, 2026

   · 

  8 min read
• Press Releases

  Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment

  October 26, 2026

   · 

  11 min read
• Press Releases

  BioMarin to Host Third Quarter 2026 Financial Results Conference Call and Webcast on Monday, November 2, 2026, at 4:30pm ET

  October 26, 2026

   · 

  1 min read
• Press Releases

  Former FDA Head Steve Hahn Joins BreakBio, a Personalized Cancer Drug Company, as Advisor

  October 26, 2026

   · 

  3 min read